---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-039005"
form_type: "8-K"
ticker: "BDX"
cik: "0000010795"
company_name: "BECTON DICKINSON & CO"
filed_at: "2026-05-29T12:39:28+00:00"
generated_at: "2026-05-29T12:40:05.707983+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BD resumes ChloraPrep shipments after voluntary hold; all final release testing acceptable

## Summary
- BD voluntarily placed ChloraPrep and PurPrep on ship hold on May 6, 2026 for additional final release testing.
- Shipments of ChloraPrep have resumed in the U.S. after completion of additional assessments and testing.
- All additional final release testing performed to date has been acceptable; no patient safety signals.
- The ship hold was in response to the FDA Warning Letter for the El Paso manufacturing facility.
- Detailed risks associated with the Warning Letter are described in BD's Q1 FY2026 10-Q filing.

## SEC filing metadata
- accession: 0001628280-26-039005
- form_type: 8-K
- ticker: BDX
- cik: 0000010795
- company_name: BECTON DICKINSON & CO
- filed_at: 2026-05-29T12:39:28+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/10795/000162828026039005/0001628280-26-039005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/10795/000162828026039005/bdx-20260529.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-039005
- JSON: https://secwatch.observer/filing/0001628280-26-039005.json
- Plain text: https://secwatch.observer/filing/0001628280-26-039005.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.